Specialty Pharmacy Providers & Specialty Pharmaceutical Manufacturers - An Evolving Partnership

SYRACUSE, N.Y., March 24, 2016 /PRNewswire/ -- Delta Marketing Dynamics (DMD) announces the release of 'Specialty Pharmacy Providers & Specialty Pharmaceutical Manufacturers – An Evolving Partnership", a white-paper (the first in a DMD Specialty Pharmaceutical White Paper Series) based on the analysis of executive-level interviews and secondary research.  It is intended for use by both Specialty Pharmacy Providers (SPPs) and Specialty Pharmaceutical manufacturers (SPMs) to help each optimize the patient's journey for important, complicated, and often costly specialty medicines.  The topics covered in this series will be focused on core issues challenging specialty pharmaceutical stakeholders today and in the future.

Specialty pharmaceuticals are a core part of the US healthcare solution.  While initially focused on rare diseases and products with challenging handling requirements, the definition for specialty pharmaceuticals is broadening.  Estimates suggest that future growth in specialty drug spending could quadruple by 2020, reaching about $400 billion or 9.1% of national health care spending.¹

"With the higher costs typically associated with specialty pharmaceuticals, distribution and delivery of these products is a key part of the value proposition which can have a significant impact on the patient journey and ultimately, clinical outcomes," said James Sharples, Vice President at Delta Marketing Dynamics, a leading marketing research consultancy in the healthcare space.  "As aspects of this distribution continue to evolve, uncertainty for both SPMs and SPPs is the norm." 

For this reason, DMD has analyzed key aspects of SPP and SPM relationships, supplementing previous secondary research with recent interviews of key executives in both SPM and SPP organizations. Key topics on this partnership whitepaper include:

• Defining elements of a strong partnership
• Components of a "Best-in Class" Partnership
• New Meaning of Partnership in Specialty Pharmaceuticals

^{1. UnitedHealth Group. The Growth of Specialty Pharmacy. Issue Brief, April 2014 
http://www.unitedhealthgroup.com/~/media/UHG/PDF/2014/UNH-The-Growth-Of-Specialty-Pharmacy.ashx}

About Delta Marketing Dynamics (DMD)

DMD is a healthcare market research consultancy focused predominantly on understanding the comprehensive pharmacy channel (including Specialty, Retail, and Hospital settings).  For over 40 years, DMD has helped clients "Know More and Connect Better" by providing key insights regarding this critical channel.

For more information or to access this whitepaper, please call James Sharples at 315-671-0811 or visit our website at http://deltamarketingdynamics.com/specialty/whitepaper2016/

Contact: 
James A. Sharples 
Vice President  
Delta Marketing Dynamics 
Phone: (315) 671-0811 
Email

SOURCE Delta Marketing Dynamics

Related Links

http://deltamarketingdynamics.com